A mathematical model of calcium and phosphorus metabolism in two forms of hyperparathyroidism

Endocrine

Volumn 41, Issue 2, 2012, Pages 309-319

  Raposo, J F ^a,b   Pires, A ^c   Yokota, H ^d   Ferreira, H G ^b  

^a The Portuguese Diabetes Association (APDP)   (Portugal)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^c HOSPITAL FERNANDO FONSECA   (Portugal)

^d Indiana University Purdue University Indianapolis   (United States)

Author keywords

Calcium and phosphorus metabolism; Epidemiology; Hyperparathyroidism; Mathematical model

Indexed keywords

CALCIMIMETIC AGENT; CALCITRIOL; CALCIUM; CALCIUM SENSING RECEPTOR; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; ARTICLE; BONE; CALCIUM METABOLISM; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HYPERPARATHYROIDISM; KIDNEY; MALE; MATHEMATICAL MODEL; METABOLIC DISORDER; PARATHYROID GLAND; PHOSPHATE METABOLISM; PRIORITY JOURNAL; REGULATORY MECHANISM; RETROSPECTIVE STUDY;

EID: 84862670156     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-011-9521-y     Document Type: Article

References (23)

1. J.F. Raposo, L.G. Sobrinho, H.G. Ferreira, A minimal mathematical model of calcium homeostasis. J. Clin. Endocrinol. Metab. 87, 4330-4340 (2002)
2. A. Pires, T. Adragão, M.J. Pais, J. Vinhas, H.G. Ferreira, Inferring disease mechanisms from epidemiological data in chronic kidney disease: calcium and phosphorus metabolism. Nephron Clin. Pract. 112, c137-c147 (2009)
3. A.M. Parfitt, M.K. Drezner, F.H. Glorieux, J.A. Kanis, H. Malluche, P.J. Meunier, S.M. Ott, R.R. Recker, Bone histomorphometry: standardization of nomenclature, symbols, and units Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2, 595-610 (1987)
4. A.M. Parfitt, Bone-forming cells in clinical conditions, in Bone. Volume 1: the osteoblast and osteocyte, ed. by B.K. Hall (Telford Press and CRC Press, Boca Raton, FL, 1990), pp. 351-429
5. A.M. Parfitt, D. Willgoss, J. Jacobi, H.M. Lloyd, Cell kinetics in parathyroid adenomas: evidence for decline in rates of cell birth and tumour growth, assuming clonal origin. Clin. Endocrinol. (Oxf) 35, 151-157 (1991)
6. A.M. Parfitt, G.D. Braunstein, A. Katz, Radiation-associated hyperparathyroidism: comparison of adenoma growth rates, inferred from weight and duration of latency, with prevalence of mitosis. J. Clin. Endocrinol. Metab. 77, 1318-1322 (1993) (Pubitemid 23345489)
7. A.M. Parfitt, Parathyroid growth: normal and abnormal, in The Parathyroids-Basic and Clinical Concepts, ed. by J.P. Bilezikian (Raven Press, New York, 1994), pp. 373-405
8. Q. Wang, S. Palnitkar, A.M. Parfitt, Parathyroid cell proliferation in the rat: effect of age and of phosphate administration and recovery. Endocrinology 137, 4558-4562 (1996) (Pubitemid 26403289)
9. A.M. Parfitt, Q. Wang, S. Palnitkar, Rates of cell proliferation in adenomatous, suppressed, and normal parathyroid tissue: implications for pathogenesis. J. Clin. Endocrinol. Metab. 83, 863-869 (1998) (Pubitemid 28496983)
10. D.S. Rao, M. Honasoge, G.W. Divine, E.R. Philips, M.W. Lee, Mo, M.R. Ansari, G.B. Talpos, A.M. Parfitt, Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. J. Clin. Endocrinol. Metab. 85, 1054-1058 (2000) (Pubitemid 32269349)
11. A.M. Parfitt, Parathyroid hormone and periosteal bone expansion. J. Bone Miner. Res. 17, 1741-1743 (2002)
12. S. Qiu, D.S. Rao, S. Palnitkar, A.M. Parfitt, Relationships between osteocyte density and bone formation rate in human cancellous bone. Bone 31, 709-711 (2002) (Pubitemid 36092095)
13. A.M. Parfitt, Misconceptions (3): calcium leaves bone only by resorption and enters only by formation. Bone 33, 259-263 (2003) (Pubitemid 37103241)
14. T.B. Drueke, E. Ritz, Treatment of secondary hyperparathyroidism in CKD patients with cinacalcet and/or Vitamin D derivatives. Clin. J. Am. Soc. Nephrol. 4, 234-241 (2009)
15. P. Evenepoel, Calcimimetics in chronic kidney disease: evidence, opportunities and challenges. Kidney Int. 74, 265-275 (2008) (Pubitemid 352001237)
16. E.M. Brown, R.J. MacLeod, Extracellular calcium sensing and extracellular calcium signaling. Physiol. Rev. 81, 240-297 (2001)
17. R.D. Mosteller, Simplified calculation of body-surface area. N. Engl. J. Med. 317, 1098 (1987)
18. A. Hald, Designs of sampling investigations and experiments, in Statistical Theory with Engineering Applications, 1st edn. (Wiley, New York, 1952), pp. 510
19. N. Weiss, Descriptive measures, in Elementary statistics, 5th edn., ed. by G. Tobin (Addison Wesley, Boston, 2002), pp. 120-121
20. C. Charytan, J.W. Coburn, M. Chonchol, J. Herman, Y.H. Lien, W. Liu, P.S. Klassen, L.C. McCary, V. Pichette, Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis. Am. J. Kidney Dis. 46, 58-67 (2005) (Pubitemid 40852012)
21. Y. Yokota, J.F. Raposo, A. Chen, C. Jiang, H.G. Ferreira, Evaluation of the role of FGF23 in mineral metabolism. Gene Regul. Syst. Biol. 3, 131-142 (2009)
22. V. Lemaire, F.L. Tobin, L.D. Greller, C.R. Cho, L.J. Suva, Modeling the interactions between osteoblast and osteoclast activities in bone remodeling. J. Theor. Biol. 229, 293-309 (2004) (Pubitemid 38844935)
23. T. Bellido, A.A. Ali, L.I. Plotkin, Q. Fu, I. Gubrij, P.K. Roberson, R.S. Weinstein, C.A. O'Brien, S.C. Manolagas, R.L. Jilka, Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism. J. Biol. Chem. 278, 50259-50272 (2003) (Pubitemid 37548867)